Concepedia

Publication | Closed Access

Requirement for Etoposide in the Treatment of Epstein-Barr Virus–Associated Hemophagocytic Lymphohistiocytosis

DOI

282

Citations

24

References

2001

Year

Shinsaku Imashuku, Kikuko Kuriyama, Tomoko Teramura, Eiichi Ishii, Naoko Kinukawa, Masahiko Katô, Masahiro Sako, Shigeyoshi Hibi
Journal of Clinical Oncology

Abstract

We conclude that early administration of etoposide, preferably with CSA, is the treatment of choice for patients with EBV-HLH.

References

YearCitations

Page 1